Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6674)
All Articles published online
|
Publishing Process of This Article
|
Oct 14, 2013 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abrahão-Machado LF, Jácome AADA, Wohnrath DR, Santos JSD, Carneseca EC, Fregnani JHTG, Scapulatempo-Neto C. HER2 in gastric cancer: Comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays. World J Gastroenterol 2013; 19(38): 6438-6446 [PMID: 24151362 DOI: 10.3748/wjg.v19.i38.6438] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i38/6438.htm |
| Number | Citing Articles |
| 1 |
Renato Santos Laboissiere, Marcelo Araújo Buzelin, Débora Balabram, Marina De Brot, Cristiana Buzelin Nunes, Rafael Malagoli Rocha, Mônica Maria Demas Álvares Cabral, Helenice Gobbi. Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0384-1
|
| 2 |
Angela N. Bartley, Mary Kay Washington, Christina B. Ventura, Nofisat Ismaila, Carol Colasacco, Al B. Benson, Alfredo Carrato, Margaret L. Gulley, Dhanpat Jain, Sanjay Kakar, Helen J. Mackay, Catherine Streutker, Laura Tang, Megan Troxell, Jaffer A. Ajani. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. Archives of Pathology & Laboratory Medicine 2016; 140(12): 1345 doi: 10.5858/arpa.2016-0331-CP
|
| 3 |
Moonsik Kim, An Na Seo. Molecular Pathology of Gastric Cancer. Journal of Gastric Cancer 2022; 22(4): 264 doi: 10.5230/jgc.2022.22.e35
|
| 4 |
Diego Michelon DE CARLI, Marta Pires da ROCHA, Luis Carlos Moreira ANTUNES, Renato Borges FAGUNDES. IMMUNOHISTOCHEMICAL EXPRESSION OF HER2 IN ADENOCARCINOMA OF THE STOMACH. Arquivos de Gastroenterologia 2015; 52(2): 152 doi: 10.1590/S0004-28032015000200015
|
| 5 |
Scott A. Robertson, Ashley Cimino-Mathews, Toby C. Cornish. HER2 Status in Gastroesophageal Adenocarcinomas: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization Methodologies. Applied Immunohistochemistry & Molecular Morphology 2018; 26(1): 35 doi: 10.1097/PAI.0000000000000382
|
| 6 |
Catalin Bogdan Satala, Ioan Jung, Raluca Ioana Stefan-van Staden, Zsolt Kovacs, Calin Molnar, Tivadar Bara, Zsolt Zoltan Fulop, Simona Gurzu, Nicola Silvestris. HER2 Heterogeneity in Gastric Cancer: A Comparative Study, Using Two Commercial Antibodies. Journal of Oncology 2020; 2020: 1 doi: 10.1155/2020/8860174
|
| 7 |
Jason Y. Park, Paul J. Zhang. HER2 testing in gastric and gastroesophageal junction adenocarcinomas. Diagnostic Histopathology 2014; 20(6): 247 doi: 10.1016/j.mpdhp.2014.03.009
|
| 8 |
Jayati Chakrabarti, Vivien Koh, Nina Steele, Jennifer Hawkins, Yoshiaki Ito, Juanita L. Merchant, Jiang Wang, Michael A. Helmrath, Syed A Ahmad, Jimmy Bok Yan So, Wei Peng Yong, Yana Zavros. Disruption of Her2-Induced PD-L1 Inhibits Tumor Cell Immune Evasion in Patient-Derived Gastric Cancer Organoids. Cancers 2021; 13(24): 6158 doi: 10.3390/cancers13246158
|
| 9 |
Chang Gok Woo, Won Jin Ho, Young Soo Park, Sook Ryun Park, Min-Hee Ryu, Hwoon-Yong Jung, Yoon-Koo Kang. A potential pitfall in evaluating HER2 immunohistochemistry for gastric signet ring cell carcinomas. Pathology 2017; 49(1): 38 doi: 10.1016/j.pathol.2016.09.064
|
| 10 |
Fatemeh Amirmoezi, Bita Geramizadeh. Molecular Classification of Gastric Cancer With Emphasis on PDL-1 Expression: The First Report From Iran. Clinical Pathology 2022; 15 doi: 10.1177/2632010X221096378
|
| 11 |
Marian Priyanthi Kumarasinghe, Daniel Houghton, Benjamin Michael Allanson, Timothy J. Price. What Therapeutic Biomarkers in Gastro-Esophageal Junction and Gastric Cancer Should a Pathologist Know About?. Surgical Pathology Clinics 2023; 16(4): 659 doi: 10.1016/j.path.2023.05.004
|
| 12 |
Esmeralda Celia Marginean. Gastric Cancer: Applicability and Feasibility of Molecular and Histological Classification in Clinical Practice. Journal of Medical and Radiation Oncology 2021; 1(2): 8 doi: 10.53011/JMRO.2021.02.02
|
| 13 |
Bob T Li, Funda Meric-Bernstam, Aditya Bardia, Yoichi Naito, Salvatore Siena, Philippe Aftimos, Ian Anderson, Giuseppe Curigliano, Maria de Miguel, Maitri Kalra, Do-Youn Oh, Joon Oh Park, Sophie Postel-Vinay, Sun Young Rha, Taroh Satoh, Iben Spanggaard, Flavia Michelini, Ann Smith, Karime Kalil Machado, Cristina Saura, Bob T Li, Funda Meric-Bernstam, Aditya Bardia, Yoichi Naito, Salvatore Siena, Philippe Aftimos, Ian Anderson, Giuseppe Curigliano, Maria de Miguel, Maitri Kalra, Do-Youn Oh, Joon Oh Park, Sophie Postel-Vinay, Sun Young Rha, Taroh Satoh, Iben Spanggaard, Flavia Michelini, Ann Smith, Karime Kalil Machado, Cristina Saura. Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study. The Lancet Oncology 2024; 25(6): 707 doi: 10.1016/S1470-2045(24)00140-2
|
| 14 |
Edwin Cevallos Barrera, Edson Zangiacomi Martinez, Mariangela Ottoboni Brunaldi, Eduardo Antonio Donadi, Ajith Kumar Sankarankutty, Rafael Kemp, José Sebastiao dos Santos. Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma. Oncotarget 2022; 13(1): 1043 doi: 10.18632/oncotarget.28275
|
| 15 |
Hiroaki Nitta, Brian D. Kelly, Craig Allred, Suzan Jewell, Peter Banks, Eslie Dennis, Thomas M. Grogan. The assessment of HER2 status in breast cancer: the past, the present, and the future. Pathology International 2016; 66(6): 313 doi: 10.1111/pin.12407
|
| 16 |
Angela N. Bartley, Mary Kay Washington, Christina B. Ventura, Nofisat Ismaila, Carol Colasacco, Al B. Benson, Alfredo Carrato, Margaret L. Gulley, Dhanpat Jain, Sanjay Kakar, Helen J. Mackay, Catherine Streutker, Laura Tang, Megan Troxell, Jaffer A. Ajani. HER2Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma. American Journal of Clinical Pathology 2016; 146(6): 647 doi: 10.1093/ajcp/aqw206
|
| 17 |
Xin Miao, Caiming Wang, Changpeng Chai, Huan Tang, Jinjing Hu, Zhenjie Zhao, Wei Luo, Hui Zhang, Kexiang Zhu, Wence Zhou, Hao Xu. Establishment of gastric cancer organoid and its application in individualized therapy. Oncology Letters 2022; 24(6) doi: 10.3892/ol.2022.13567
|
| 18 |
Lucas Faria Abrahao-Machado, Cristovam Scapulatempo-Neto. HER2 testing in gastric cancer: An update. World Journal of Gastroenterology 2016; 22(19): 4619-4625 doi: 10.3748/wjg.v22.i19.4619
|
| 19 |
Vincent Drubay, Frederiek Nuytens, Florence Renaud, Antoine Adenis, Clarisse Eveno, Guillaume Piessen. Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management. World Journal of Gastrointestinal Oncology 2022; 14(8): 1406-1428 doi: 10.4251/wjgo.v14.i8.1406
|
| 20 |
Katharina Kolbe, Ivonne Haffner, Katrin Schierle, Dieter Maier, Birgitta Geier, Birgit Luber, Hendrik Bläker, Christian Wittekind, Florian Lordick. Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study. Journal of Cancer Research and Clinical Oncology 2023; 149(3): 1319 doi: 10.1007/s00432-022-04208-6
|
| 21 |
Angela N. Bartley, Mary Kay Washington, Carol Colasacco, Christina B. Ventura, Nofisat Ismaila, Al B. Benson, Alfredo Carrato, Margaret L. Gulley, Dhanpat Jain, Sanjay Kakar, Helen J. Mackay, Catherine Streutker, Laura Tang, Megan Troxell, Jaffer A. Ajani. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology. Journal of Clinical Oncology 2017; 35(4): 446 doi: 10.1200/JCO.2016.69.4836
|
| 22 |
Kyung-Ju Kim, Tae Hun Lee, Jung Ho Kim, Nam-Yun Cho, Woo Ho Kim, Gyeong Hoon Kang. Deletion in HSP110 T17: correlation with wild-type HSP110 expression and prognostic significance in microsatellite-unstable advanced gastric cancers. Human Pathology 2017; 67: 109 doi: 10.1016/j.humpath.2017.08.001
|
| 23 |
Jason Y. Park, Kerry B. Dunbar, Roopa Vemulapalli, David H. Wang, Paul J. Zhang. Human epidermal growth factor receptor 2 testing in gastric and gastroesophageal junction adenocarcinomas: role of the gastroenterologist. Gastrointestinal Endoscopy 2015; 81(4): 977 doi: 10.1016/j.gie.2014.12.040
|
| 24 |
Nina G. Steele, Jayati Chakrabarti, Jiang Wang, Jacek Biesiada, Loryn Holokai, Julie Chang, Lauren M. Nowacki, Jennifer Hawkins, Maxime Mahe, Nambirajan Sundaram, Noah Shroyer, Mario Medvedovic, Michael Helmrath, Syed Ahmad, Yana Zavros. An Organoid-Based Preclinical Model of Human Gastric Cancer. Cellular and Molecular Gastroenterology and Hepatology 2019; 7(1): 161 doi: 10.1016/j.jcmgh.2018.09.008
|
| 25 |
Marta Smolińska, Dariusz Grzanka, Paulina Antosik, Anna Kasperska, Izabela Neska-Długosz, Jakub Jóźwicki, Anna Klimaszewska-Wiśniewska. HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters. Disease Markers 2019; 2019: 1 doi: 10.1155/2019/6315936
|